Data from Suppression of <i>SIN3A</i> by miR-183 Promotes Breast Cancer Metastasis

Abstract

<div>Abstract<p>Recent work has established that SWI-independent-3 (SIN3) chromatin modification complexes play key roles in cancer progression. We previously demonstrated that knockdown of SIN3A expression promotes human breast cancer cell invasion and metastasis; however, the levels of SIN3A in patient breast carcinoma are not known. We therefore examined SIN3A mRNA and protein in patient tissues and determined that SIN3A expression is lower in breast carcinoma relative to normal breast. Given the 3′—untranslated region (UTR) of <i>SIN3A</i> has several conserved binding sites for oncogenic miRNA, we hypothesized that <i>SIN3A</i> is targeted by miRNA and found that ectopic miR-183 results in decreased SIN3A in breast carcinoma cell lines. Functionally, we demonstrate that miR-183 promotes breast cancer cell migration and invasion in a SIN3A-dependent manner and ectopic miR-183 promotes metastasis <i>in vivo</i>. Patients with breast cancer with high levels of miR-183 and low levels of <i>SIN3A</i> have the shortest overall survival. Given the critical link between metastasis and survival in patients with breast cancer, it is of utmost importance to identify clinically relevant genes involved in metastasis. Here, we report for the first time the aberrant expression of the putative metastasis suppressing gene SIN3A in human breast cancers and propose a mechanism of SIN3A suppression by miR-183.</p>Implications:<p>SIN3A expression is decreased in metastatic breast cancer in part due to miR-183.</p></div>